The University of Chicago Header Logo

Connection

Girish Venkataraman to Middle Aged

Back to Details
This is a "connection" page, showing publications Girish Venkataraman has written about Middle Aged.
Girish Venkataraman
Connection Strength
0.455
Middle Aged
  1. Challenges in the Diagnosis of Gray Zone Lymphomas. Surg Pathol Clin. 2019 Sep; 12(3):709-718.
    View in: PubMed
    Score: 0.046
  2. The thin line between CML and CMML. Blood. 2017 04 27; 129(17):2456.
    View in: PubMed
    Score: 0.040
  3. Chediak-Higashi–like granules within leukemic promyelocytes. Blood. 2013 Nov 07; 122(19):3250.
    View in: PubMed
    Score: 0.031
  4. Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Am J Clin Pathol. 2013 May; 139(5):651-61.
    View in: PubMed
    Score: 0.030
  5. Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood. 2013 Mar 07; 121(10):1795-804.
    View in: PubMed
    Score: 0.030
  6. CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology. 2011 Apr; 58(5):803-5.
    View in: PubMed
    Score: 0.026
  7. Adult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells. Hum Pathol. 2011 Jul; 42(7):1042-6.
    View in: PubMed
    Score: 0.026
  8. Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol. 2011 Mar; 24(3):355-66.
    View in: PubMed
    Score: 0.026
  9. Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer. Prostate. 2007 Oct 01; 67(14):1524-36.
    View in: PubMed
    Score: 0.021
  10. Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer J. 2021 02 18; 11(2):39.
    View in: PubMed
    Score: 0.013
  11. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study. Genes Chromosomes Cancer. 2020 08; 59(8):484-494.
    View in: PubMed
    Score: 0.012
  12. Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma. Leukemia. 2020 08; 34(8):2238-2242.
    View in: PubMed
    Score: 0.012
  13. Rosai-Dorfman Disease of the Breast With Variable IgG4+ Plasma Cells: A Diagnostic Mimicker of Other Malignant and Reactive Entities. Am J Surg Pathol. 2019 12; 43(12):1653-1660.
    View in: PubMed
    Score: 0.012
  14. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood Adv. 2019 10 08; 3(19):2790-2799.
    View in: PubMed
    Score: 0.012
  15. Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide. Am J Clin Pathol. 2019 10 07; 152(5):675-685.
    View in: PubMed
    Score: 0.012
  16. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS). Ann Diagn Pathol. 2019 Dec; 43:151404.
    View in: PubMed
    Score: 0.012
  17. PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype. Blood. 2019 05 23; 133(21):2279-2290.
    View in: PubMed
    Score: 0.011
  18. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities. Appl Immunohistochem Mol Morphol. 2019 03; 27(3):180-184.
    View in: PubMed
    Score: 0.011
  19. Predominance of CD4+ T Cells in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma and Identification of a Subset of Patients With Peripheral B-Cell Lymphopenia. Am J Clin Pathol. 2017 Jun 01; 147(6):596-603.
    View in: PubMed
    Score: 0.010
  20. Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL. Oncotarget. 2016 Oct 18; 7(42):68833-68841.
    View in: PubMed
    Score: 0.010
  21. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Mod Pathol. 2016 10; 29(10):1173-82.
    View in: PubMed
    Score: 0.009
  22. De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Am J Hematol. 2016 Jun; 91(4):395-9.
    View in: PubMed
    Score: 0.009
  23. Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leuk Lymphoma. 2016; 57(4):866-71.
    View in: PubMed
    Score: 0.009
  24. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol. 2013 Jun; 37(6):816-26.
    View in: PubMed
    Score: 0.008
  25. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011 May 05; 117(18):4726-35.
    View in: PubMed
    Score: 0.007
  26. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010 Mar; 34(3):405-17.
    View in: PubMed
    Score: 0.006
  27. Oncocytic epithelial-myoepithelial carcinoma: an evolving new variant with comparative immunohistochemistry. Pathology. 2008 Jun; 40(4):415-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.